Litcius/Paper detail

Inhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe Hypertriglyceridemia

Zahid Ahmad, Robert Pordy, Daniel J. Rader, Daniel Gaudet, Shazia Ali, Claudia Gonzaga‐Jauregui, Manish P. Ponda, Brad Shumel, Poulabi Banerjee, Richard L. Dunbar

2021Journal of the American College of Cardiology53 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHypertriglyceridemiaAngiopoietin 2AngiopoietinInternal medicineGastroenterologyTriglycerideVEGF receptorsCholesterolVascular endothelial growth factorLipid metabolism and disordersCancer, Lipids, and MetabolismDiabetes, Cardiovascular Risks, and Lipoproteins
Inhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe Hypertriglyceridemia | Litcius